EMPIRE BIO A/S Financials, key figures and credit report
Gross profit 6 676.8 kDKK FY 2025 +13% vs 2024
EBIT -4.8 kDKK FY 2025 +98.8% vs 2024
Net debt - 329.1 kDKK FY 2025 +32.5% vs 2024
Quick ratio 0.4 FY 2025 -0.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 6 071.77 | 6 158.89 | 6 139.57 | 5 909.41 | 6 676.80 |
| Employee benefit expenses | -5 039.10 | -5 434.25 | -5 541.29 | -5 374.34 | -5 709.36 |
| Total depreciation | - 830.79 | - 806.96 | - 869.29 | - 945.12 | - 972.24 |
| EBIT | 201.88 | -82.32 | - 271.01 | - 410.05 | -4.80 |
| Other financial income | 3.76 | ||||
| Other financial expenses | -41.84 | -28.86 | -15.38 | -55.73 | |
| Pre-tax profit | 160.04 | - 111.18 | - 271.01 | - 421.67 | -60.53 |
| Income taxes | -34.75 | 26.53 | 61.00 | 95.00 | 6.00 |
| Net earnings | 125.29 | -84.64 | - 210.01 | - 326.67 | -54.53 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 4 541.60 | 3 937.68 | 3 956.10 | 3 920.24 | 4 942.89 |
| Machinery and equipment | 214.28 | 267.46 | 386.60 | 368.17 | 344.38 |
| Tangible assets total | 4 755.88 | 4 205.14 | 4 342.70 | 4 288.41 | 5 287.27 |
| Investments total | 780.50 | 800.26 | 839.31 | 856.70 | 875.45 |
| Long term receivables total | |||||
| Finished products/goods | 349.47 | 369.43 | 296.50 | 321.17 | 215.73 |
| Advance payments | 52.42 | ||||
| Inventories total | 349.47 | 369.43 | 296.50 | 321.17 | 268.15 |
| Current trade debtors | 293.85 | 562.30 | 439.59 | 497.77 | 253.70 |
| Prepayments and accrued income | 19.10 | 20.82 | 20.09 | 79.40 | 48.72 |
| Current other receivables | 261.88 | 71.31 | 95.42 | 315.58 | 363.72 |
| Current deferred tax assets | 185.20 | 162.16 | 117.51 | 150.00 | 132.00 |
| Short term receivables total | 760.03 | 816.59 | 672.62 | 1 042.75 | 798.14 |
| Cash and bank deposits | 4 343.84 | 2 547.65 | 1 270.87 | 487.66 | 329.06 |
| Cash and cash equivalents | 4 343.84 | 2 547.65 | 1 270.87 | 487.66 | 329.06 |
| Balance sheet total (assets) | 10 989.72 | 8 739.08 | 7 421.99 | 6 996.69 | 7 558.07 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 1 380.00 | 1 380.00 | 1 380.00 | 1 380.00 | 1 380.00 |
| Retained earnings | 3 349.12 | 3 474.41 | 3 389.77 | 3 179.75 | 2 853.08 |
| Profit of the financial year | 125.29 | -84.64 | - 210.01 | - 326.67 | -54.53 |
| Shareholders equity total | 4 854.41 | 4 769.77 | 4 559.75 | 4 233.08 | 4 178.55 |
| Provisions | 60.00 | 34.00 | |||
| Non-current other liabilities | 145.99 | ||||
| Non-current deferred tax liabilities | 145.99 | 145.99 | 145.99 | 165.47 | |
| Non-current liabilities total | 145.99 | 145.99 | 145.99 | 145.99 | 165.47 |
| Advances received | 237.86 | 222.57 | 223.35 | 225.16 | 210.24 |
| Current trade creditors | 1 071.46 | 1 258.15 | 1 450.99 | 1 517.75 | 2 111.56 |
| Other non-interest bearing current liabilities | 4 620.00 | 2 308.60 | 1 041.91 | 874.71 | 892.24 |
| Current liabilities total | 5 929.32 | 3 789.32 | 2 716.24 | 2 617.63 | 3 214.05 |
| Balance sheet total (liabilities) | 10 989.72 | 8 739.08 | 7 421.99 | 6 996.69 | 7 558.07 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated